afatinib (gilotrif) Report issue

Small molecule Orphan Drug FDA Approved FDA Fast Track FDA Priority Review FDA
Back

Drug Pricing Summary

AUS PBS

$76.9247

VA FSS

$174.1403 - $179.6187

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
afatinib 20 mg (TABLET) $76.9247 AUS PBS generic
  • Giotrif (28)
  • Boehringer Ingelheim Pty Ltd
    afatinib 20 mg (TABLET) $175.7373 VA FSS
  • Gilotrif (30)
  • Boehringer Ingelheim Pharmaceuticals, Inc.
    afatinib 30 mg (TABLET) $76.9247 AUS PBS generic
  • Giotrif (28)
  • Boehringer Ingelheim Pty Ltd
    afatinib 30 mg (TABLET) $174.1403 VA FSS
  • Gilotrif (30)
  • Boehringer Ingelheim Pharmaceuticals, Inc.
    afatinib 40 mg (TABLET) $76.9247 AUS PBS generic
  • Giotrif (28)
  • Boehringer Ingelheim Pty Ltd
    afatinib 40 mg (TABLET) $179.6187 VA FSS
  • Gilotrif (30)
  • Boehringer Ingelheim Pharmaceuticals, Inc.
    afatinib 50 mg (TABLET) $76.9247 AUS PBS generic
  • Giotrif (28)
  • Boehringer Ingelheim Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue